Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stock Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

MDNA stock

Medicenna Therapeutics Corp (NASDAQ:MDNA) Stock Extends Sell-Off: Down 32% in a Month

Medicenna Therapeutics Corp (NASDAQ:MDNA) dropped 10%, and in a month, the stock has shed 32%. The company announced the publication of its pre-clinical MDNA109 data in a peer-reviewed journal, Frontiers in Immunology, authored by University of Helsinki researchers and from other institutions. MDNA109 is the company’s IL-2 Superkine platform which forms MDNA11’s basis. CEO Fahar …

Continue reading “Medicenna Therapeutics Corp (NASDAQ:MDNA) Stock Extends Sell-Off: Down 32% in a Month”

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
*By submitting your information you agree to the terms of our Privacy Policy. You will receive the DRP Journal newsletter, and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.